Cargando…
A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines
INTRODUCTION: Hyperuricemia and gout are receiving an increasing scientific and medical attention because of their relatively high prevalence and their association with relevant co-morbidities. Recently, it has been suggested that gout patients have an altered gut microbiota. The first objective of...
Autores principales: | Rodríguez, Juan M., Garranzo, Marco, Segura, José, Orgaz, Belén, Arroyo, Rebeca, Alba, Claudio, Beltrán, David, Fernández, Leónides |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971985/ https://www.ncbi.nlm.nih.gov/pubmed/36865781 http://dx.doi.org/10.3389/fmicb.2023.1111652 |
Ejemplares similares
-
Immunomodulation of the Vaginal Ecosystem by Ligilactobacillus salivarius CECT 30632 Improves Pregnancy Rates among Women with Infertility of Unknown Origin or Habitual Abortions
por: Fernández, Leónides, et al.
Publicado: (2023) -
Administration of Ligilactobacillus salivarius CECT 30632 to elderly during the COVID-19 pandemic: Nasal and fecal metataxonomic analysis and fatty acid profiling
por: Mozota, Marta, et al.
Publicado: (2022) -
Application of Ligilactobacillus salivarius CECT5713 to Achieve Term Pregnancies in Women with Repetitive Abortion or Infertility of Unknown Origin by Microbiological and Immunological Modulation of the Vaginal Ecosystem
por: Fernández, Leónides, et al.
Publicado: (2021) -
Immunomodulatory effects of inactivated Ligilactobacillus salivarius CECT 9609 on respiratory epithelial cells
por: Bravo, María, et al.
Publicado: (2023) -
Replacement of Metaphylactic Antimicrobial Therapy by Oral Administration of Ligilactobacillus salivarius MP100 in a Pig Farm
por: Sobrino, Odón J., et al.
Publicado: (2021)